![Kris Siemionow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kris Siemionow
Algemeen Directeur bij Holo Surgical, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Pawel Lewicki | M | 70 |
Holo Surgical, Inc.
![]() Holo Surgical, Inc. Medical SpecialtiesHealth Technology Holo Surgical, Inc. engages in operation of a digital surgery company. Its technology focuses on improving patient outcomes by bringing Augmented Reality and Artificial Intelligence to the operating room. The company was founded by Cristian Luciano and Kris Siemionow in 2015 and is headquartered in Chicago, IL.
Dystrogen Therapeutics Corp.
![]() Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | 8 jaar |
Maria Siemionow | M | - |
Dystrogen Therapeutics Corp.
![]() Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | 7 jaar |
Cristian Luciano | M | - |
Holo Surgical, Inc.
![]() Holo Surgical, Inc. Medical SpecialtiesHealth Technology Holo Surgical, Inc. engages in operation of a digital surgery company. Its technology focuses on improving patient outcomes by bringing Augmented Reality and Artificial Intelligence to the operating room. The company was founded by Cristian Luciano and Kris Siemionow in 2015 and is headquartered in Chicago, IL. | 9 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Edyta Niemczyk | M | - |
Dystrogen Therapeutics Corp.
![]() Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 4 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Kris Siemionow
- Persoonlijk netwerk